We are thrilled to announce that Mentaily has successfully raised $3,000,000 in our latest funding round—a transformative investment that reinforces our commitment to revolutionizing mental health care through cutting-edge innovation. As a trailblazer in the mental health space, Mentaily leverages AI and GenAI to bridge critical gaps in care, and our flagship product, Liv, stands at the forefront of this mission. Liv is an AI-powered Clinical Decision Support System (CDSS) designed to enhance psychiatric intake processes by delivering DSM-5-compliant clinical summaries five times faster than traditional methods, thereby streamlining triage, diagnostics, and treatment planning for clinicians around the globe. Recognized as the First Place Winner in Reboot & Ynet’s Mental Health Initiatives Track, our award-winning innovation is built on robust AI-driven insights that utilize multi-dimensional frameworks and advanced prompt designs to continuously improve clinical outcomes.
This funding will be instrumental in accelerating the further development and scalability of Liv, allowing us to integrate even more advanced machine learning capabilities and expand our strategic partnerships with industry leaders like Sheba Medical Center and Microsoft. With these additional resources, we are set to enhance personalized and culturally adaptive care plans, implement real-time safety assessments, and ensure that our solutions remain secure and engaging for patients. Ultimately, our vision stands clear: to empower clinicians with state-of-the-art AI tools, reduce patient wait times, and dramatically improve mental health outcomes across diverse communities. This funding milestone not only validates our innovative approach but also marks a significant step forward in our journey to transform mental health care delivery worldwide.
